Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC385011773;11774;11775 chr2:178741685;178741684;178741683chr2:179606412;179606411;179606410
N2AB353310822;10823;10824 chr2:178741685;178741684;178741683chr2:179606412;179606411;179606410
N2ANoneNone chr2:Nonechr2:None
N2B348710684;10685;10686 chr2:178741685;178741684;178741683chr2:179606412;179606411;179606410
Novex-1361211059;11060;11061 chr2:178741685;178741684;178741683chr2:179606412;179606411;179606410
Novex-2367911260;11261;11262 chr2:178741685;178741684;178741683chr2:179606412;179606411;179606410
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Ig-27
  • Domain position: 31
  • Structural Position: 45
  • Q(SASA): 0.8237
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/E None None 0.012 N 0.442 0.075 None gnomAD-4.0.0 1.59128E-06 None None None None I None 0 0 None 0 0 None 0 0 2.8584E-06 0 0
K/R rs763263943 0.004 None N 0.25 0.08 None gnomAD-2.1.1 4.02E-06 None None None None I None 0 0 None 0 0 None 3.27E-05 None 0 0 0
K/R rs763263943 0.004 None N 0.25 0.08 None gnomAD-4.0.0 1.59128E-06 None None None None I None 0 0 None 0 0 None 0 0 0 1.43275E-05 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.2707 likely_benign 0.2848 benign -0.062 Destabilizing 0.016 N 0.325 neutral None None None None I
K/C 0.6809 likely_pathogenic 0.7212 pathogenic -0.211 Destabilizing 0.864 D 0.423 neutral None None None None I
K/D 0.4166 ambiguous 0.4171 ambiguous 0.106 Stabilizing 0.072 N 0.495 neutral None None None None I
K/E 0.1008 likely_benign 0.0976 benign 0.135 Stabilizing 0.012 N 0.442 neutral N 0.456904444 None None I
K/F 0.7136 likely_pathogenic 0.7061 pathogenic -0.127 Destabilizing 0.214 N 0.453 neutral None None None None I
K/G 0.4112 ambiguous 0.4323 ambiguous -0.306 Destabilizing 0.072 N 0.485 neutral None None None None I
K/H 0.2959 likely_benign 0.3101 benign -0.609 Destabilizing 0.214 N 0.487 neutral None None None None I
K/I 0.2614 likely_benign 0.2489 benign 0.513 Stabilizing 0.001 N 0.297 neutral N 0.508425192 None None I
K/L 0.3145 likely_benign 0.3215 benign 0.513 Stabilizing 0.016 N 0.331 neutral None None None None I
K/M 0.1953 likely_benign 0.191 benign 0.257 Stabilizing 0.356 N 0.489 neutral None None None None I
K/N 0.2615 likely_benign 0.258 benign 0.149 Stabilizing 0.055 N 0.45 neutral N 0.501537122 None None I
K/P 0.7803 likely_pathogenic 0.8388 pathogenic 0.351 Stabilizing 0.136 N 0.562 neutral None None None None I
K/Q 0.1077 likely_benign 0.113 benign 0.006 Stabilizing None N 0.164 neutral N 0.496674728 None None I
K/R 0.0834 likely_benign 0.0867 benign -0.154 Destabilizing None N 0.25 neutral N 0.503373505 None None I
K/S 0.304 likely_benign 0.2988 benign -0.364 Destabilizing 0.016 N 0.423 neutral None None None None I
K/T 0.1411 likely_benign 0.1388 benign -0.171 Destabilizing None N 0.199 neutral N 0.47886906 None None I
K/V 0.2537 likely_benign 0.2485 benign 0.351 Stabilizing 0.001 N 0.269 neutral None None None None I
K/W 0.7534 likely_pathogenic 0.7719 pathogenic -0.114 Destabilizing 0.864 D 0.434 neutral None None None None I
K/Y 0.5648 likely_pathogenic 0.5711 pathogenic 0.218 Stabilizing 0.356 N 0.474 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.